Genetic and epigenetic alterations in pancreatic neuroendocrine tumors.
Pancreatic neuroendocrine tumors (PNETs)
epigenetics
genetics
Journal
Journal of gastrointestinal oncology
ISSN: 2078-6891
Titre abrégé: J Gastrointest Oncol
Pays: China
ID NLM: 101557751
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
14
7
2020
pubmed:
14
7
2020
medline:
14
7
2020
Statut:
ppublish
Résumé
Neuroendocrine tumors (NETs) are a heterogenous group of tumors that originate from neuroendocrine cells, mainly in the pancreas and the gastrointestinal and bronchopulmonary tracts. There has been considerable progress in our understanding of the genetic and epigenetic changes associated with pancreatic NETs (PNETs). The main genetic alterations that drive PNETs include genetic alterations in
Identifiants
pubmed: 32655936
doi: 10.21037/jgo.2020.03.11
pii: jgo-11-03-567
pmc: PMC7340809
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
567-577Informations de copyright
2020 Journal of Gastrointestinal Oncology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jgo.2020.03.11). The series “Pancreatic Neuroendocrine Tumors” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Oncologist. 2016 Jun;21(6):671-5
pubmed: 27226359
Endocr Rev. 2019 Apr 1;40(2):506-536
pubmed: 30657883
J Gastrointest Surg. 2010 Mar;14(3):541-8
pubmed: 19997980
Mol Cancer Res. 2004 Feb;2(2):89-95
pubmed: 14985465
Endocr Relat Cancer. 2014 May 06;21(3):R153-63
pubmed: 24322304
Science. 2011 Jul 22;333(6041):425
pubmed: 21719641
Future Oncol. 2018 Jan;14(2):111-122
pubmed: 29072093
J Clin Endocrinol Metab. 2000 Nov;85(11):4146-56
pubmed: 11095446
Mol Cell. 2018 Oct 4;72(1):37-47.e4
pubmed: 30197296
Nature. 2017 Mar 2;543(7643):65-71
pubmed: 28199314
Clin Cancer Res. 2017 Jan 15;23(2):600-609
pubmed: 27407094
J Clin Oncol. 2010 Jan 10;28(2):245-55
pubmed: 19917848
N Engl J Med. 2011 Feb 10;364(6):501-13
pubmed: 21306237
J Clin Endocrinol Metab. 2016 Feb;101(2):353-8
pubmed: 26678657
Ann Oncol. 2017 Apr 1;28(4):904-905
pubmed: 28327903
Histopathology. 2018 Jan;72(1):168-177
pubmed: 29239037
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2212-2217.e1
pubmed: 30580091
Neuroendocrinology. 2017;104(1):26-32
pubmed: 26731483
Ann Oncol. 2013 Jan;24(1):152-60
pubmed: 22967994
Fam Cancer. 2018 Apr;17(2):275-280
pubmed: 28887784
Dig Liver Dis. 2019 Apr;51(4):595-599
pubmed: 30824408
Neuroendocrinology. 2017 Feb 11;105(3):196-200
pubmed: 28190015
Lancet. 2003 Jun 14;361(9374):2059-67
pubmed: 12814730
Neuroendocrinology. 2018;107(3):237-245
pubmed: 29991024
Oncotarget. 2016 Mar 15;7(11):12633-50
pubmed: 26871472
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011
pubmed: 22723327
PLoS One. 2019 Jun 3;14(6):e0217399
pubmed: 31158244
Surgery. 2007 Dec;142(6):814-8; discussion 818.e1-2
pubmed: 18063061
Endocr Relat Cancer. 2018 Feb;25(2):L1-L5
pubmed: 29167182
Science. 2011 Mar 4;331(6021):1199-203
pubmed: 21252315
Hum Genet. 2000 Apr;106(4):425-31
pubmed: 10830910
Pediatr Ann. 2017 Apr 1;46(4):e166-e171
pubmed: 28414398
Gastroenterology. 2014 Feb;146(2):453-60.e5
pubmed: 24148618
J Med Genet. 1991 Jul;28(7):443-7
pubmed: 1895313
N Engl J Med. 2011 Feb 10;364(6):514-23
pubmed: 21306238
Cancer Res. 2001 Jul 1;61(13):5186-92
pubmed: 11431358
Nat Commun. 2018 Oct 12;9(1):4158
pubmed: 30315258
JAMA Oncol. 2017 Oct 1;3(10):1335-1342
pubmed: 28448665
N Engl J Med. 2005 Mar 10;352(10):997-1003
pubmed: 15758010
Nat Med. 2019 Aug;25(8):1260-1265
pubmed: 31263286
Endocr Pract. 2019 Jun;25(6):580-588
pubmed: 30865533
Nat Rev Genet. 2013 Nov;14(11):765-80
pubmed: 24105274
J Clin Endocrinol Metab. 2015 May;100(5):E776-82
pubmed: 25763608
Endocr Relat Cancer. 2018 Sep;25(9):783-793
pubmed: 29748190
J Cell Sci. 2007 Sep 15;120(Pt 18):3163-72
pubmed: 17878233
Am J Surg Pathol. 2016 Sep;40(9):1192-202
pubmed: 27259015
Clin Cancer Res. 2016 Jan 1;22(1):250-8
pubmed: 26169971
Cancer. 2019 Apr 15;125(8):1247-1257
pubmed: 30620390
Eur J Endocrinol. 2002 Oct;147(4):507-13
pubmed: 12370114
J Mol Endocrinol. 2012 Jun 26;49(1):R37-50
pubmed: 22586144
Br J Cancer. 2001 Jul 20;85(2):209-12
pubmed: 11461078
Neuroendocrinology. 2014;100(4):310-6
pubmed: 25342539
Cancer Res. 1998 Jan 15;58(2):237-40
pubmed: 9443399
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Nat Commun. 2013;4:2810
pubmed: 24326773
Am J Hum Genet. 2016 May 5;98(5):830-842
pubmed: 27087319
Nat Rev Clin Oncol. 2016 Sep;13(9):537-49
pubmed: 27030075
Cancer Res Treat. 2018 Jul;50(3):917-925
pubmed: 29020732
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1631-1638
pubmed: 29294023
Mutat Res. 2013 Mar-Apr;743-744:33-43
pubmed: 23507534
J Clin Endocrinol Metab. 2010 Oct;95(10):4592-9
pubmed: 20660056
Eur J Endocrinol. 2016 Jun;174(6):R275-90
pubmed: 27165966
Cancer. 2015 Feb 15;121(4):589-97
pubmed: 25312765
Am J Surg Pathol. 2012 Feb;36(2):173-84
pubmed: 22251937
N Engl J Med. 2014 Jul 17;371(3):224-33
pubmed: 25014687
Neuroendocrinology. 2016;103(2):186-94
pubmed: 26731334
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S1-16
pubmed: 22005112
Oncol Rep. 2005 Jul;14(1):47-52
pubmed: 15944766
Hum Mutat. 1995;5(1):66-75
pubmed: 7728151
Eur J Endocrinol. 2018 Sep;179(3):153-160
pubmed: 29903750
J Clin Oncol. 2016 Jun 20;34(18):2172-81
pubmed: 27114602
Cancer Res. 1999 Jan 15;59(2):311-5
pubmed: 9927038
JAMA Oncol. 2018 Jan 1;4(1):124-126
pubmed: 29075773
Gastric Cancer. 2018 Nov;21(6):1058-1063
pubmed: 29968043
BMJ Open. 2015 May 19;5(5):e008248
pubmed: 25991462
Cancer Res. 2003 Feb 15;63(4):817-23
pubmed: 12591732
J Clin Endocrinol Metab. 2000 Jan;85(1):116-23
pubmed: 10634374
Nat Genet. 2013 Dec;45(12):1483-6
pubmed: 24185511
J Clin Oncol. 2009 Oct 1;27(28):4656-63
pubmed: 19704057